Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial - The Lancet
UDCA
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' - Journal of Hepatology
Gallstone-dissolving agents: Nursing Pharmacology | Osmosis
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Nature Reviews Gastroenterology & Hepatology
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' - Journal of Hepatology
The ascending pathophysiology of cholestatic liver disease - Jansen - 2017 - Hepatology - Wiley Online Library
The Farnesoid X Receptor | Arteriosclerosis, Thrombosis, and Vascular Biology
Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy El-Gendy FM, Bahbah WA, Al Kafory EE - Menoufia Med J
Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease | SpringerLink
Ursodeoxycholic acid - Wikipedia
Ursodiol (Ursodeoxycholic Acid) - LiverTox - NCBI Bookshelf
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity - Journal of Hepatology
Ursodeoxycholic acid | C24H40O4 - PubChem
Ursofalk Full Prescribing Information, Dosage & Side Effects | MIMS Singapore
Ursodeoxycholic acid | C24H40O4 - PubChem
Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial | The BMJ
Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? | The BMJ
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity - ScienceDirect
Ursodeoxycholic acid - Wikipedia
Ursodeoxycholic acid: Mechanism of action and novel clinical applications - Ikegami - 2008 - Hepatology Research - Wiley Online Library
Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? | American Journal of Physiology-Gastrointestinal and Liver Physiology
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' - Journal of Hepatology
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction | Scientific Reports
Ursodeoxycholic acid - Therapeutic Goods Administration
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' - Journal of Hepatology
